The Dishwasher Buying Guide
That’s lower in cost!
In 2019, a new GSK facility started production in Parma, Italy.The initial requirement was to design and build a pharmaceutical facility in 15 months that would usually have taken closer to three years to complete, in order to maintain supply of a life-saving treatment for people with HIV.
We achieved this mould-breaking pharmaceutical facility by, as described, investing significant time and focus in modelling the problem before going anywhere near construction..The Parma project is an evidenced demonstration that our Design to Value approach made it possible to design, construct and commission a new pharmaceutical manufacturing facility in record time without increasing budgets or compromising on any aspect of quality.. A proven approach: shaping the future of construction with DtV.At Bryden Wood, we do not come to a project with a ready-made solution.
We bring only our Design to Value approach, using the combined powers of data, construction technology and imagination to establish what the most effective solution will be.. We have been working this way for over 25 years., delivering major design and construction projects in pharmaceutical and process facilities, data centres, aviation, healthcare, education, residential, water infrastructure, transport infrastructure, custodial facilities… It has unlimited applications.. Our Design to Value approach is proven to deliver better results for the built environment, and for our clients..
It is being done.. To learn more about our Design to Value philosophy, read Design to Value: The architecture of holistic design and creative technology by Mark Bryden, John Dyson, Jaimie Johnston MBE and Martin Wood.
Available to purchase at.Adam Jordan, Asia-Pacific lead at Bryden Wood, reviews developments in Design for Manufacture and Assembly (DfMA), construction platforms (P-DfMA) and Modern Methods of Construction (MMC) in Asian markets.. Bryden Wood is focused on developing innovative approaches to improve the efficiency and productivity of the construction industry.In the latter he has specialised in early-stage project development, working in British Nuclear Group’s decommissioning group and with GSK’s global project development group (the ‘front-end-factory’)..
He specialises in the application of process simulation to capital projects, particularly the application of tools commonly used in other sectors, such as dynamic and discrete-event methods and batch processes.Adrian has developed and led approaches to managing process development and scale-up projects, and their integration with capital projects.Alastair is a chartered architect designing innovative facilities in the life sciences and broader industrial and energy sectors.
He is particularly interested in finding fast, scalable solutions to big global challenges, such as climate change or vaccine production, and uses a range of methods to achieve this including:.Design to Value.